Azole antifungals inhibit CYP51A1-mediated sterol 14 alpha-demethylati
on and the mechanism(s) of resistance to such compounds in Ustilago ma
ydis were examined, The inhibition of growth was correlated with the a
ccumulation of the substrate, 24-methylene-24,25-dihydrolanosterol (eb
uricol), and depletion of ergosterol, Mutants overcoming the effect of
azole antifungal treatment exhibited a unique phenotype with leaky CY
P51A1. activity which was resistant to inhibition, The results demonst
rate that alterations at the level of inhibitor binding to the target
site can produce azole resistance, Similar changes may account for fun
gal azole resistance phenomena in agriculture, and also in medicine wh
ere resistance has become a problem in immunocompromised patients suff
ering from AIDS.